However, in rhinoviral infection, the antibody could not demonstrate any improvement in asthmatic condition.99 Targeting of TLR3 is currently used as adjuvant therapy, along with other drugs or vaccines, against a variety of cancers; nonetheless, the sole activation of TLR3 to curb any disease has yet to be successfully explored (Table 3). The gene discussed is TLR3; the disease is cancer.